QRX003-4% Lotion QAM

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromeNCT05521438Quoin PharmaceuticalsPhase 2, Phase 3Active not recruiting2025-12-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.